SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,730,988 | -49.6% | 1,987,559 | +1.3% | 0.00% | 0.0% |
Q2 2023 | $9,394,909 | +1.3% | 1,961,358 | +19.9% | 0.00% | 0.0% |
Q1 2023 | $9,273,342 | +104024.7% | 1,635,509 | +2.8% | 0.00% | 0.0% |
Q4 2022 | $8,906 | -99.9% | 1,590,395 | +5.6% | 0.00% | 0.0% |
Q3 2022 | $9,671,000 | +131.4% | 1,506,494 | +23.6% | 0.00% | 0.0% |
Q2 2022 | $4,180,000 | -51.5% | 1,218,748 | +0.8% | 0.00% | 0.0% |
Q1 2022 | $8,610,000 | -16.5% | 1,209,317 | -2.3% | 0.00% | 0.0% |
Q4 2021 | $10,307,000 | +55.0% | 1,237,362 | +29.5% | 0.00% | 0.0% |
Q3 2021 | $6,649,000 | -74.8% | 955,344 | -13.6% | 0.00% | -75.0% |
Q2 2021 | $26,385,000 | +31.7% | 1,106,322 | +13.7% | 0.00% | +33.3% |
Q1 2021 | $20,034,000 | -7.7% | 973,044 | +9.8% | 0.00% | -25.0% |
Q4 2020 | $21,707,000 | -4.0% | 886,045 | +10.9% | 0.00% | 0.0% |
Q3 2020 | $22,623,000 | +544.0% | 799,134 | +8.3% | 0.00% | +300.0% |
Q2 2020 | $3,513,000 | +48.7% | 738,121 | +11.5% | 0.00% | 0.0% |
Q1 2020 | $2,362,000 | -44.9% | 661,718 | -46.7% | 0.00% | – |
Q4 2019 | $4,284,000 | +95.1% | 1,241,870 | +126.7% | 0.00% | -100.0% |
Q3 2019 | $2,196,000 | +48.0% | 547,862 | +18.8% | 0.00% | – |
Q2 2019 | $1,484,000 | -22.3% | 461,106 | +65.9% | 0.00% | – |
Q1 2019 | $1,909,000 | -11.1% | 277,957 | -41.6% | 0.00% | – |
Q4 2018 | $2,148,000 | +25.1% | 475,548 | +110.1% | 0.00% | – |
Q3 2018 | $1,717,000 | -11.8% | 226,298 | -0.0% | 0.00% | -100.0% |
Q2 2018 | $1,946,000 | +16.6% | 226,397 | -0.5% | 0.00% | 0.0% |
Q1 2018 | $1,669,000 | -21.4% | 227,522 | +8.7% | 0.00% | 0.0% |
Q4 2017 | $2,123,000 | -22.7% | 209,395 | +22.3% | 0.00% | 0.0% |
Q3 2017 | $2,747,000 | +42.9% | 171,282 | +0.7% | 0.00% | 0.0% |
Q2 2017 | $1,922,000 | +2.6% | 170,095 | +2.3% | 0.00% | 0.0% |
Q1 2017 | $1,874,000 | +20.4% | 166,325 | +5.8% | 0.00% | 0.0% |
Q4 2016 | $1,556,000 | -9.5% | 157,265 | +12.4% | 0.00% | 0.0% |
Q3 2016 | $1,719,000 | -34.2% | 139,945 | +55.6% | 0.00% | 0.0% |
Q2 2016 | $2,612,000 | +27.8% | 89,929 | +16.8% | 0.00% | 0.0% |
Q1 2016 | $2,044,000 | -22.4% | 76,975 | +2.5% | 0.00% | -50.0% |
Q4 2015 | $2,635,000 | +33.6% | 75,109 | +12.8% | 0.00% | +100.0% |
Q3 2015 | $1,973,000 | – | 66,582 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $93,092,000 | 26.99% |
ARK Investment Management | 2,406,723 | $17,665,000 | 0.88% |
Virtus ETF Advisers LLC | 76,713 | $563,000 | 0.49% |
Bison Wealth, LLC | 33,929 | $249,000 | 0.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 19,525 | $143,000 | 0.10% |
Rock Springs Capital Management LP | 220,000 | $1,615,000 | 0.07% |
FEDERATED HERMES, INC. | 1,766,681 | $12,968,000 | 0.04% |
Spark Investment Management LLC | 79,500 | $583,000 | 0.04% |
A.R.T. Advisors, LLC | 45,952 | $337,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 88,684 | $651,000 | 0.01% |